Director/PDMR Shareholding

RNS Number : 1688A

GlaxoSmithKline PLC

02 October 2009

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 30 September 2009, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £12.41 per Ordinary share and $39.60 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2009 to 30 September 2009:

Non Executive Director	Ordinary Shares	American Depository  Shares (ADSs)
Sir Christopher Gent	2,719.58
Prof. Sir Roy Anderson	528.810
Dr Stephanie Burns		330.08
Mr Lawrence Culp		330.08
Sir Crispin Davis	1,913.78
Sir Deryck Maughan		330.080
Mr James Murdoch	377.72
Dr Daniel Podolsky		424.39
Mr Tom de Swaan	528.81
Sir Robert Wilson	528.81

The Company and the Non-Executive Directors were informed of these allocations on 2 October 2009.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

2 October 2009

 

END

 

 

RDSXLLFBKBBZFBQ